Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MUC1 peptide-Poly-ICLC vaccine |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
MUC1 peptide-Poly-ICLC vaccine is a cancer vaccine comprising MUC1 peptide and poly-ICLC, which potentially enhances immune response against MUC1-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C82417 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| DNAJB1-PRKACA peptide vaccine + Ipilimumab + MUC1 peptide-Poly-ICLC vaccine + Nivolumab | DNAJB1-PRKACA peptide vaccine Ipilimumab MUC1 peptide-Poly-ICLC vaccine Nivolumab | 0 | 0 |
| MUC1 peptide-Poly-ICLC vaccine | MUC1 peptide-Poly-ICLC vaccine | 0 | 1 |